Skip to main content

Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Investor Securities Class Action Lawsuit 11/17/2016

  • If you purchased shares of Alexion Pharmaceuticals Inc (NASDAQ: ALXN), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 19, 2021 - The court granted in part and denied in part the defendants' motion to dismiss. August 2, 2019 - A motion to dismiss the amended consolidated complaint was filed. June 2, 2019 - An amended consolidated complaint was filed. December 30, 2016 - The case was transferred to the U.S. District Court for the District of Connecticut. November 17, 2016 - An investor in shares...



You must register (for free) or login to view the entire case.